Primaquine Interactions

Increased risk of methemoglobinemia when concurrently exposed to articaine.

Source: NLP:articaine hydrochloride and epinephrine

Increased risk of developing methemoglobinemia when concurrently exposed to this antimalarial.

Source: NLP:articaine hydrochloride, epinephrine bitartrate

Increased risk of methemoglobinemia when concurrently exposed to this antimalarial oxidizing agent with local anesthetics.

Source: NLP:benzocaine, butamben, and tetracaine hydrochloride

Increased risk of methemoglobinemia when concurrently exposed with bupivacaine.

Source: NLP:bupivacaine hydrochloride

Induces methemoglobinemia; concomitant use may increase risk for developing methemoglobinemia.

Source: NLP:dapsone

Increased risk of methemoglobinemia when used concurrently with lidocaine.

Source: NLP:lidocaine

Antimalarial that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.

Source: NLP:lidocaine 5%

Antimalarial drug that increases risk of methemoglobinemia when used concurrently with lidocaine and capsaicin patch.

Source: NLP:lidocaine and capsaicin

Antimalarial; increased risk of methemoglobinemia when concurrently exposed.

Source: NLP:lidocaine and prilocaine

Increased risk of methemoglobinemia when used concurrently with lidocaine hydrochloride.

Source: NLP:lidocaine hydrochloride

Antimalarial associated with increased methemoglobinemia risk when used concurrently.

Source: NLP:lidocaine hydrochloride and epinephrine bitartrate

Increased risk of methemoglobinemia when lidocaine is concurrently exposed to antimalarials.

Source: NLP:lidocaine and menthol

Increased risk of methemoglobinemia when local anesthetics are concurrently exposed to antimalarials.

Source: NLP:lidothol patch

Increased risk of methemoglobinemia when concurrently exposed to antimalarials.

Source: NLP:marcaine, lidocaine, povidone iodine

Concurrent exposure increases risk of methemoglobinemia in patients administered mepivacaine.

Source: NLP:mepivacaine hydrochloride

Increased risk of methemoglobinemia when penicillin is concurrently administered with primaquine (an antimalarial).

Source: NLP:penicillin g benzathine and penicillin g procaine

Increased risk of methemoglobinemia when prilocaine is concurrently exposed to primaquine.

Source: NLP:prilocaine hcl and epinephrine

Increased risk of methemoglobinemia when used concurrently with prilocaine.

Source: NLP:prilocaine hydrochloride

Increased risk of developing methemoglobinemia when concurrently exposed to primaquine.

Source: NLP:ropivacaine hydrochloride

Increased risk of methemoglobinemia when concurrently exposed.

Source: NLP:bupivacaine hydrochloride, lidocaine hydrochloride, triamcinolone acetonide, povidine iodine

May increase risk of methemoglobinemia when concurrently exposed with bupivacaine.

Source: NLP:bupivacaine

Increased risk of methemoglobinemia when concurrently exposed to antimalarials with bupivacaine.

Source: NLP:methylprednisolone acetate, bupivacaine hydrochloride, povidone-iodine